Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection

Document Details

Document Type
Pub Defense Publication
Publication Date
Aug 01, 2021
Source ID
10.1016/j.vaccine.2021.06.085

Entities

People

  • Erin M. Harberts
  • Florian Krammer
  • Matthew B. Frieman
  • Robert Haupt
  • Robert K Ernst
  • Robert Kitz
  • Shirin Strohmeier

Organizations

  • Biomedical Advanced Research and Development Authority
  • National Institute of Allergy and Infectious Diseases